The amblyopia treatment index

Stephen R. Cole, Roy W. Beck, Pamela S. Moke, Marianne P. Celano, Carolyn D. Drews, Michael X. Repka, Jonathan M Holmes, Eileen E. Birch, Raymond T. Kraker, Kevin E. Kip

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Objective: To develop a questionnaire to assess the acceptability of amblyopia treatment and its effect on the child and family. Methods: A 20-item parental survey was developed and pilot tested on 64 subjects, aged 3 to 6 years, participating in the Amblyopia Treatment Study, a randomized trial comparing patching and atropine as treatments for moderate amblyopia. The survey was administered after 4 weeks of treatment. A descriptive item analysis and an internal consistency reliability analysis were performed. Results: Nineteen of the 20 items demonstrated adequate variability as evidenced by the frequency distributions for item responses. Only 4 (<1%) of 1280 possible item responses were missing, one each by 4 different respondents. Factor analysis identified 3 treatment-related factors - "adverse effects," "compliance," and "social stigma" - among 11 of the 20 items. The internal-consistency reliability α for the 5-item adverse effects subscale was 0.82, the 4-item compliance subscale α was 0.81, and the 2-item social stigma subscale α was 0.84. Conclusions: The Amblyopia Treatment Index appears to be a useful instrument for assessing the impact of amblyopia treatment in 3-to 6-year-old children.

Original languageEnglish (US)
Pages (from-to)250-254
Number of pages5
JournalJournal of AAPOS
Volume5
Issue number4
DOIs
StatePublished - Aug 2001

Fingerprint

Amblyopia
Social Stigma
Therapeutics
Compliance
Atropine
Statistical Factor Analysis
Surveys and Questionnaires

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Cole, S. R., Beck, R. W., Moke, P. S., Celano, M. P., Drews, C. D., Repka, M. X., ... Kip, K. E. (2001). The amblyopia treatment index. Journal of AAPOS, 5(4), 250-254. https://doi.org/10.1067/mpa.2001.117097

The amblyopia treatment index. / Cole, Stephen R.; Beck, Roy W.; Moke, Pamela S.; Celano, Marianne P.; Drews, Carolyn D.; Repka, Michael X.; Holmes, Jonathan M; Birch, Eileen E.; Kraker, Raymond T.; Kip, Kevin E.

In: Journal of AAPOS, Vol. 5, No. 4, 08.2001, p. 250-254.

Research output: Contribution to journalArticle

Cole, SR, Beck, RW, Moke, PS, Celano, MP, Drews, CD, Repka, MX, Holmes, JM, Birch, EE, Kraker, RT & Kip, KE 2001, 'The amblyopia treatment index', Journal of AAPOS, vol. 5, no. 4, pp. 250-254. https://doi.org/10.1067/mpa.2001.117097
Cole SR, Beck RW, Moke PS, Celano MP, Drews CD, Repka MX et al. The amblyopia treatment index. Journal of AAPOS. 2001 Aug;5(4):250-254. https://doi.org/10.1067/mpa.2001.117097
Cole, Stephen R. ; Beck, Roy W. ; Moke, Pamela S. ; Celano, Marianne P. ; Drews, Carolyn D. ; Repka, Michael X. ; Holmes, Jonathan M ; Birch, Eileen E. ; Kraker, Raymond T. ; Kip, Kevin E. / The amblyopia treatment index. In: Journal of AAPOS. 2001 ; Vol. 5, No. 4. pp. 250-254.
@article{190dc9d51c0640d38e0e9c0795a54a63,
title = "The amblyopia treatment index",
abstract = "Objective: To develop a questionnaire to assess the acceptability of amblyopia treatment and its effect on the child and family. Methods: A 20-item parental survey was developed and pilot tested on 64 subjects, aged 3 to 6 years, participating in the Amblyopia Treatment Study, a randomized trial comparing patching and atropine as treatments for moderate amblyopia. The survey was administered after 4 weeks of treatment. A descriptive item analysis and an internal consistency reliability analysis were performed. Results: Nineteen of the 20 items demonstrated adequate variability as evidenced by the frequency distributions for item responses. Only 4 (<1{\%}) of 1280 possible item responses were missing, one each by 4 different respondents. Factor analysis identified 3 treatment-related factors - {"}adverse effects,{"} {"}compliance,{"} and {"}social stigma{"} - among 11 of the 20 items. The internal-consistency reliability α for the 5-item adverse effects subscale was 0.82, the 4-item compliance subscale α was 0.81, and the 2-item social stigma subscale α was 0.84. Conclusions: The Amblyopia Treatment Index appears to be a useful instrument for assessing the impact of amblyopia treatment in 3-to 6-year-old children.",
author = "Cole, {Stephen R.} and Beck, {Roy W.} and Moke, {Pamela S.} and Celano, {Marianne P.} and Drews, {Carolyn D.} and Repka, {Michael X.} and Holmes, {Jonathan M} and Birch, {Eileen E.} and Kraker, {Raymond T.} and Kip, {Kevin E.}",
year = "2001",
month = "8",
doi = "10.1067/mpa.2001.117097",
language = "English (US)",
volume = "5",
pages = "250--254",
journal = "Journal of AAPOS",
issn = "1091-8531",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - The amblyopia treatment index

AU - Cole, Stephen R.

AU - Beck, Roy W.

AU - Moke, Pamela S.

AU - Celano, Marianne P.

AU - Drews, Carolyn D.

AU - Repka, Michael X.

AU - Holmes, Jonathan M

AU - Birch, Eileen E.

AU - Kraker, Raymond T.

AU - Kip, Kevin E.

PY - 2001/8

Y1 - 2001/8

N2 - Objective: To develop a questionnaire to assess the acceptability of amblyopia treatment and its effect on the child and family. Methods: A 20-item parental survey was developed and pilot tested on 64 subjects, aged 3 to 6 years, participating in the Amblyopia Treatment Study, a randomized trial comparing patching and atropine as treatments for moderate amblyopia. The survey was administered after 4 weeks of treatment. A descriptive item analysis and an internal consistency reliability analysis were performed. Results: Nineteen of the 20 items demonstrated adequate variability as evidenced by the frequency distributions for item responses. Only 4 (<1%) of 1280 possible item responses were missing, one each by 4 different respondents. Factor analysis identified 3 treatment-related factors - "adverse effects," "compliance," and "social stigma" - among 11 of the 20 items. The internal-consistency reliability α for the 5-item adverse effects subscale was 0.82, the 4-item compliance subscale α was 0.81, and the 2-item social stigma subscale α was 0.84. Conclusions: The Amblyopia Treatment Index appears to be a useful instrument for assessing the impact of amblyopia treatment in 3-to 6-year-old children.

AB - Objective: To develop a questionnaire to assess the acceptability of amblyopia treatment and its effect on the child and family. Methods: A 20-item parental survey was developed and pilot tested on 64 subjects, aged 3 to 6 years, participating in the Amblyopia Treatment Study, a randomized trial comparing patching and atropine as treatments for moderate amblyopia. The survey was administered after 4 weeks of treatment. A descriptive item analysis and an internal consistency reliability analysis were performed. Results: Nineteen of the 20 items demonstrated adequate variability as evidenced by the frequency distributions for item responses. Only 4 (<1%) of 1280 possible item responses were missing, one each by 4 different respondents. Factor analysis identified 3 treatment-related factors - "adverse effects," "compliance," and "social stigma" - among 11 of the 20 items. The internal-consistency reliability α for the 5-item adverse effects subscale was 0.82, the 4-item compliance subscale α was 0.81, and the 2-item social stigma subscale α was 0.84. Conclusions: The Amblyopia Treatment Index appears to be a useful instrument for assessing the impact of amblyopia treatment in 3-to 6-year-old children.

UR - http://www.scopus.com/inward/record.url?scp=0040156199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0040156199&partnerID=8YFLogxK

U2 - 10.1067/mpa.2001.117097

DO - 10.1067/mpa.2001.117097

M3 - Article

VL - 5

SP - 250

EP - 254

JO - Journal of AAPOS

JF - Journal of AAPOS

SN - 1091-8531

IS - 4

ER -